[email protected]

  • Follow
  • Follow
  • Follow
Crestone logo
  • Company
    • About Us
    • Team
    • Code of Ethics
    • Careers
    • Press Releases
  • Pipeline
    • CRS3123 for C. difficile
    • CRS0540 Gram-positives
    • CRS0393 NTM/TB
  • Knowledge Portal
  • Contact Us
Crestone Sponsors Peggy Lillis Foundation FIGHT C. DIFF. Gala

Crestone Sponsors Peggy Lillis Foundation FIGHT C. DIFF. Gala

by Crestone, Inc. | Dec 12, 2022 | Events

Crestone is proud to be a sponsor of the Peggy Lillis Foundation FIGHT C. DIFF. Gala in Brooklyn, NY on October 28, 2022.
Keystone Symposia: Antimicrobial Resistance & Microbiome Presentation

Keystone Symposia: Antimicrobial Resistance & Microbiome Presentation

by Crestone, Inc. | Dec 12, 2022 | Events

Keystone Symposia Presentation Details Poster: Phase 2 Clinical Trial Design for CRS3123, a Novel Narrow-Spectrum Agent in Development to Treat C. difficile Infections
Presentation at the World Antiviral Conference 2022

Presentation at the World Antiviral Conference 2022

by Crestone, Inc. | Dec 12, 2022 | Events

World Antiviral Conference 2022 Presentation Details Oral presentation: Broad-Spectrum Antivirals against Respiratory Viruses
Presentation: World Antimicrobial Resistance (WAMR) Conference 2022

Presentation: World Antimicrobial Resistance (WAMR) Conference 2022

by Crestone, Inc. | Dec 12, 2022 | Events

WAMR Conference 2022 Presentation Details Poster Presentation: Addressing the AMR Challenge: Antibiotics with a Novel Mode of Action in Development to Treat Infections Caused by C. difficile, Gram-positive Pathogens, and Mycobacteria
Preventative Measures that Can be Taken to Avoid MRSA Infections And MRSA Symptoms & Diagnosis Information

Preventative Measures that Can be Taken to Avoid MRSA Infections
And MRSA Symptoms & Diagnosis Information

by Crestone, Inc. | Dec 7, 2022 | Information

Methicillin-resistant Staphylococcus aureus (MRSA) is a type of staph bacteria that has developed an immunity to certain antibiotics. Medications like methicillin, which were once efficacious in eliminating this microorganism, are now ineffective. This makes MRSA...
« Older Entries
Next Entries »

Copyright © Crestone, Inc. 2024. All Rights Reserved. Website by tekRESCUE